/
Atarax: Ease out discomfort and embarrassment to Pruritus in your patients
Where to use?
Atarax: A Hydroxyzine Antihistamine is used for treatment of Itch/skin allergies that are produced by histamine in the body during dermatitis & Eczema.
Atarax contains Hydroxyzine, which is an Antihistamine that reduces the effects of natural chemical Histamine in the body and helps manage itching during dermatitis & Eczema
-
Bookmark this
buttonBookmark this
-
Bookmark this
buttonBookmark this
-
Bookmark this
buttonBookmark this
Why Hydroxyzine?
Hydroxyzine is used to treat itching caused by allergies. It is an Antihistamine and works by blocking a certain natural substance (Histamine) that body makes during allergic reactions during some conditions like dermatitis, Eczema, and Chronic Utricaria. Hydroxyzine may als be used short-term to treat Anxiety as it reduces the activity in the Central Nervous System, and it also helps you feel sleepy/relaxed before and after surgery.
Knowledge Hub
-
Hydroxyzine: An Effective Antihistamine and the Drug of Choice for Pruritus
-
Fever with skin rashes one of the first presentation of COVID-19
-
Study: Itch in children v/s itch in adults
-
Review: Emerging fungal infections in children and their iclinical manifestations, diagnosis, and prevention
-
Guidelines: How to avoid Misdiagnosis and Mistreatment of Atopic Dermatitis
-
First-generation antihistamines improves pruritus
-
Diabetes can cause local Itching
-
Common skin itching during monsoon
-
Pramoxine Hydrochloride improves Uremic Pruritis: Review Article
-
Underlying cause identification of chronic itch: Recent Research
-
Uremic Pruritus in Hemodialysis Patient: Trial Report
-
Uremic Pruritus: Therapies & their efficacy
-
Uremic Pruritus in patients with CKD
-
Promaxine-based Anti-itch Lotion v/s Control Lotion
-
Atopic Dermatitis: Clinically Meaningful Changes
-
Treatment Guidelines: Optimal Care of the Pediatric Patient with Psoriasis
-
Novel Systemic Therapies reveal promising results in care for patients with Atopic Dermatitis
-
Neonatal rash due to Pemphigoid Gestationis
-
Study: Multidisciplinary approach yields better outcome in treatment of Pediatric Atopic Dermatitis
-
Pediatric Atopic Dermatitis: New developments in therapies for transformation of management
-
Study Report: How to manage Annular Lesions in Pediatric Population
-
Case Study: Giant Urticaria and Acral Peeling in a Child with COVID‐19 associated manifestations
-
H1-Antihistamines and itch in Atopic Dermatitis
-
Itch Management for Diabetics
-
Atarax Anti-itch Lotion – Symptomatic & Soothing Relief from Itch
-
Itch in children
-
Atarax: The most effective treatment for itch
-
Study: Management of Scabies with Ivermectin-based MDA
-
Review highlights: A stepwise Pharmacological approach to treat Chronic Idiopathic Urticaria
-
Atopic Dermatitis is a risk factor for Attention Deficit/Hyperactivity Disorder
-
Study: New drug advancement for AD set to reduce its Global burden
-
Study: Treating Vulvar Pruritus Multimodal Strategy with an Interdisciplinary Approach
-
Summary by Italian Expert Group: Pruritus in children with AD
-
British Association of Dermatologists: Hydroxyzine improves GPUO in adults
-
Report: Efficacy of Hydroxyzine to manage Uremic Pruritus in Hemodialysis patients
-
Recent Developments: Latest Approach to identify Cause and Management of Chronic Itch
-
Beneficial Effects of H-1 Antihistamine in Dermatological practices other than Itch and Urticaria Control
-
Guidelines: Treating Atopic Dermatitis (Consensus-based)
-
Novel Systemic Therapies for patients with Atopic Dermatitis
-
Study: Molecular pathways of Psoriatic Itch
